Full history for every metric is available with a Kvantra account
Winsan (Chengdu) Medical Science and Technology Co., Ltd. (600767.SS)
Key financial summary
Financials in CNY| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | CNY m | 113 | 207 | 132 | 49 | 52 | 46 | 44 |
| Operating profit | CNY m | -0 | - | |||||
| Net profit | CNY m | 43 | 20 | -82 | 10 | 14 | -35 | -38 |
| EPS reported | CNY | -0.10 | -0.11 | |||||
| Operating cashflow per share | CNY | -0.04 | -0.04 | |||||
| Capex per share | CNY | 0.00 | 0.00 | |||||
| FCF per share | CNY | -0.04 | -0.04 | |||||
| Free cash flow | CNY m | -14 | -39 | |||||
| Net debt | CNY m | -36 | -26 | |||||
| Book value equity | CNY m | 201 | 196 | |||||
| Book value per share | CNY | 0.59 | 0.57 | |||||
| Number of shares | m | 341.6 | 340.36 | |||||
| DPS (TTM paid) | CNY | 0.00 | 0.00 |
Financial summary
Financials in CNY| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 7.92 | 0.73 | |||||
| P/S LTM | x | 34.50 | 3.28 | |||||
| P/FCF LTM | x | -116.88 | -3.72 | |||||
| EV/EBITDA LTM | x | -57.14 | -104.26 | |||||
| EV/Sales LTM | x | 33.72 | 2.70 | |||||
| Earnings Yield LTM | % | -2.22% | -24.63% | |||||
| FCF Yield | % | -0.86% | -26.91% | |||||
| Quality | ||||||||
| ROE | % | -17.55% | -15.91% | |||||
| ROIC | % | -0.02% | -0.02% | |||||
| Operating margin | % | -0.10% | -0.10% | |||||
| Gross margin | % | 52.51% | 52.51% | |||||
| FCF/Sales | % | -29.51% | -29.51% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -10.84% | - | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.02% | 0.00% | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | -1.09% | -0.78% | |||||
| FCF/Debt | x | -1.02 | -3.17 | |||||
| Net Debt/EBITDA | x | 1.32 | 1.32 | |||||
| EBIT/Net interest | x | -0.03 | -0.03 | |||||
| Net debt/market cap | % | -2.26% | -17.92% | |||||
| Net debt/Equity | x | -0.18 | -0.13 | |||||
| Gross debt/equity | x | 0.07 | 0.06 | |||||
Company overview
Winsan (Chengdu) Medical Science and Technology Co., Ltd. is a Chinese enterprise dedicated to a broad spectrum of healthcare services and solutions. Its operations encompass medical digitalization, remote healthcare, online health management platforms, and the provision of medical equipment and direct patient care. The company develops extensive health information systems, offering tools for regional population health insights, traditional Chinese medicine integration, and optimizing hospital performance. These systems also support home-based elder care, chronic disease management, telemedicine consultations, medical insurance processing, and pharmacy services. Furthermore, Winsan operates the Jingde County Chinese Medicine Hospital, a non-profit, second-class facility specializing in traditional Chinese medicine. They also supply medical institutions with crucial items like testing reagents, instruments, and consumables, alongside delivering clinical diagnostic services. Founded in 1993, the company adopted its current name in April 2020, having previously been known as Winsan (Shanghai) Medical Science and Technology Co., Ltd., and maintains its headquarters in Shanghai, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Winsan (Chengdu) Medical Science and Technology Co., Ltd. (600767.SS)
Winsan (Chengdu) Medical Science and Technology Co., Ltd. is a Chinese enterprise dedicated to a broad spectrum of healthcare services and solutions. Its operations encompass medical digitalization, remote healthcare, online health management platforms, and the provision of medical equipment and direct patient care. The company develops extensive health information systems, offering tools for regional population health insights, traditional Chinese medicine integration, and optimizing hospital performance. These systems also support home-based elder care, chronic disease management, telemedicine consultations, medical insurance processing, and pharmacy services. Furthermore, Winsan operates the Jingde County Chinese Medicine Hospital, a non-profit, second-class facility specializing in traditional Chinese medicine. They also supply medical institutions with crucial items like testing reagents, instruments, and consumables, alongside delivering clinical diagnostic services. Founded in 1993, the company adopted its current name in April 2020, having previously been known as Winsan (Shanghai) Medical Science and Technology Co., Ltd., and maintains its headquarters in Shanghai, China.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free